Home » Business, Fitness, Health & Medicine, Pharmaceuticals & Biotech, Science » Venous Thromboembolism 2017 -Market Insights & Drugs Sales Forecast (VTE) 2020

“”Venous Thromboembolism””
WiseGuyReports.com adds “Venous Thromboembolism Market 2017 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2020”reports to its database.

Venous Thromboembolism Market:

Executive Summary

The Venous Thromboembolism- Market Insights & Drugs Sales Forecast (VTE) -2020 report provides an overview of the disease, epidemiology and global market trends for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. According to DelveInsight, Global VTE market was $4.2 billion in 2015 and expected to grow to $4.75 billion by 2020 with a compound annual growth rate (CAGR) of 2.44%.

Globally the overall incidence for Venous Thromboembolism (VTE) is increasing at a higher rate. For VTE, there are approximately 1 million cases in the United States each year, many of which represent recurrent disease. The increasing epidemiology of venous thromboembolism is a key driver for the global anticoagulants market.

Key Coverage and Benefits:

  • The report will help in developing business strategies by understanding the trends shaping and driving the global Venous Thromboembolism (VTE) market.
  • Identifying patient populations in the global Venous Thromboembolism (VTE) market to improve product design, pricing, and launch plans.
  • Organize sales and marketing efforts by identifying the best opportunities for Venous Thromboembolism (VTE) therapeutics in each of the markets covered.
  • To understand the future market competition in the global Venous Thromboembolism (VTE) therapeutics market and Insightful review of the key market drivers and barriers.

Scope of the Report:

  • Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.
  • Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.
  • The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2015-2020.
  • It also provides Venous Thromboembolism (VTE) for United States, EU5 and Japan from 2015 and forecasted Market to 2020.

Request Sample Report @ https://www.wiseguyreports.com/sample-request/476537-venous-thromboembolism-market-insights-drugs-sales-forecast-vte-2020

Table of Contents

Executive Summary 
Market Share of Anticoagulants in 2015 and 2020 
Worldwide Market Share of Anticoagulants in 2015 
Worldwide Market Share of Anticoagulants in 2020 
Chapter 1 Anticoagulants Introduction 
Warfarin 
Low Molecular Weight Heparins 
New Oral Anticoagulants (NOAC) 
Chapter 2 Venous Thromboembolism 
Disease Overview 
Epidemiology of Venous Thromboembolism 
Treatment Landscape 
Treatment Algorithm 
Treatment Goals 
Treatment Details 
Chapter 3 Key Marketed Anticoagulants 
Novel Oral Anticoagulants Comparison 
Reversal Agents (Antidotes) 
Chapter 4 Anticoagulants Market Assessment by VTE 
Key Findings 
Global Anticoagulants Market Sales by Venous Thromboembolism 
Global Anticoagulants Market Share (%) in Venous Thromboembolism 
Chapter 5 United States Anticoagulants Market Assessment 
Key Findings 
United States Anticoagulants Market Sales by Venous Thromboembolism 
United States Anticoagulants Market Share (%) in Venous Thromboembolism 
Chapter 6 Europe 5 Anticoagulants Market Assessment 
Key Findings 
Europe 5 Anticoagulants Market Sales by Venous Thromboembolism 
Europe 5 Anticoagulants Market Share (%) in Venous Thromboembolism 
Chapter 7 Japan Anticoagulants Market Assessment 
Key Findings 
Japan Anticoagulants Market Sales by Venous Thromboembolism 
Japan Anticoagulants Market Share (%) in Venous Thromboembolism 
Chapter 8 Xarelto (rivaroxaban) Drug Profile 
Product Profile 

For further information on this report, please visit – https://www.wiseguyreports.com/enquiry/476537-venous-thromboembolism-market-insights-drugs-sales-forecast-vte-2020

….

List of Tables and Figures

Figure 1 Global Anticoagulants Sales in Venous Thromboembolism- 2011-2020 
Figure 2 Global Anticoagulants Market Share (%) in Venous Thromboembolism – 2011-2020 
Figure 3 US Anticoagulants Sales in Venous Thromboembolism- 2011-2020 
Figure 4 US Anticoagulants Market Share (%) in Venous Thromboembolism – 2011-2020 
Figure 5 EU5 Anticoagulants Sales in Venous Thromboembolism- 2011-2020 
Figure 6 EU5 Anticoagulants Market Share (%) in Venous Thromboembolism – 2011-2020 
Figure 7 Japan Anticoagulants Sales in Venous Thromboembolism- 2011-2020 
Figure 8 Japan Anticoagulants Market Share (%) in Venous Thromboembolism – 2011-2020 
Figure 9 Xarelto Historical Sales and Forecasted Sales (2011-2020) (USD MM) 
Figure 10 Xarelto Sales by Venous Thromboembolism (VTE)(USD MM) 
Figure 11 Xarelto, Clinical Trials by Zone (%), 2016 
Figure 12 Pradaxa Historical Sales and Forecasted Sales (2011-2020) (USD MM) 
Figure 13 Pradaxa Sales by Venous Thromboembolism (VTE)(USD MM) 
Figure 14 Pradaxa, Clinical Trials by Zone (%), 2016 
Figure 15 Eliquis Historical Sales and Forecasted Sales (2011-2020) (USD MM) 
Figure 16 Eliquis Sales by Venous Thromboembolism (VTE)(USD MM) 
Figure 17 Eliquis, Clinical Trials by Zone (%), 2016 
Figure 18 SavaysaHistorical Sales and Forecasted Sales (2011-2020) (USD MM) 
Figure 19 Savaysa Sales by Venous Thromboembolism (VTE)(USD MM) 
Figure 20 Savaysa, Clinical Trials by Zone (%), 2016 
Figure 21 Lovenox Historical Sales and Forecasted Sales (2011-2020) (USD MM) 
Figure 22 Lovenox Sales by Venous Thromboembolism (VTE)(USD MM) 
Figure 23 Lovenox, Clinical Trials by Zone (%), 2016 
Figure 24 Fraxiparine Historical Sales and Forecasted Sales (2011-2020) (USD MM) 
Figure 25 Fraxiparine Sales by Venous Thromboembolism (VTE)(USD MM) 
Figure 26 Fraxiparine, Clinical Trials by Zone (%), 2016 
Figure 27 ArixtraHistorical Sales and Forecasted Sales (2011-2020) (USD MM) 
Figure 28 Arixtra Sales by Venous Thromboembolism (VTE)(USD MM) 
Figure 29 Arixtra, Clinical Trials by Zone (%), 2016 
Figure 30 BetrixabanForecasted Sales (2011-2020) (USD MM) 
Figure 31 Betrixaban Sales by Venous Thromboembolism (VTE)(USD MM) 
Figure 32 Betrixaban, Clinical Trials by Zone (%), 2016      

…CONTINUED

Buy this Report @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=476537

 

Media Contact
Company Name: Wiseguyreports.com
Contact Person: Norah Trent
Email: sales@wiseguyreports.com
Phone: +1 646 845 9349, +44 208 133 9349
City: Pune
State: Maharashtra
Country: India
Website: www.wiseguyreports.com

Comments are closed.